Quarry LP’s Fulcrum Therapeutics FULC Stock Holding History

Quarry LP’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,165	Closed	-$194K	–	1728
2025 Q4	$194K	Buy	17,165 +13,391	+355%	+$136K	0.03%	278
2025 Q3	$34.7K	Buy	+3,774	New	+$27.3K	0.01%	1067

Other funds holding FULC

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Quarry LP's FULC Position: Q1 2026 in Review

Quarry LP sold out of Fulcrum Therapeutics (FULC) in Q1 2026, closing a stake of 17,165 shares — an estimated $194K sold.

Quarry LP first reported a position in FULC in Q3 2025 and held it in 2 quarters. The position peaked at $194K in Q4 2025. 169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

Quarry LP reported no remaining Fulcrum Therapeutics position as of Q1 2026 after selling out during the quarter.
Quarry LP sold 17,165 Fulcrum Therapeutics shares in Q1 2026, an estimated $194K.
Quarry LP first reported a position in Fulcrum Therapeutics in Q3 2025 and held it in 2 quarters.
Quarry LP's Fulcrum Therapeutics position peaked at $194K in Q4 2025.
169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.